🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 11 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/01/2025 36,98 37,43 36,34 36,82 +0,77% 2,95% 485.300
16/01/2025 37,52 37,68 35,03 36,54 -3,69% 7,06% 672.700
15/01/2025 37,66 40,07 37,57 37,94 +3,46% 6,64% 699.300
14/01/2025 37,29 37,32 36,45 36,67 -1,27% 2,33% 439.200
13/01/2025 36,02 37,16 35,47 37,14 +1,45% 4,69% 623.900
10/01/2025 36,80 37,64 36,30 36,61 -2,68% 3,64% 493.200
08/01/2025 38,46 38,90 36,95 37,62 -2,16% 5,07% 670.600
07/01/2025 38,28 39,18 38,03 38,45 +0,95% 3,01% 1.060.400
06/01/2025 39,45 39,85 37,48 38,09 -3,74% 6,01% 747.300
03/01/2025 38,82 40,16 38,70 39,57 +1,51% 3,77% 375.200
02/01/2025 38,85 39,62 38,58 38,98 +0,98% 2,69% 468.000
31/12/2024 39,00 39,86 38,13 38,60 +0,23% 4,44% 419.600
30/12/2024 38,57 38,85 38,04 38,51 -1,16% 2,10% 304.600
27/12/2024 39,20 39,68 38,50 38,96 -1,39% 3,01% 469.800
26/12/2024 38,98 39,67 38,85 39,51 +0,53% 2,12% 402.200
24/12/2024 40,43 40,44 38,90 39,30 -3,20% 3,81% 249.300
23/12/2024 41,20 41,28 40,07 40,60 -2,15% 2,92% 875.800
20/12/2024 39,01 41,68 38,91 41,49 +4,93% 7,10% 2.368.500
19/12/2024 38,94 40,00 38,61 39,54 +1,33% 3,57% 747.200
18/12/2024 40,71 41,18 38,62 39,02 -4,10% 6,30% 636.700
17/12/2024 40,99 41,13 39,63 40,69 -1,86% 3,65% 512.300
16/12/2024 41,19 41,97 41,05 41,46 +0,93% 2,23% 691.500
13/12/2024 40,35 41,46 39,60 41,08 +1,73% 4,60% 530.600
12/12/2024 41,69 42,08 39,85 40,38 -1,51% 5,35% 584.400
11/12/2024 41,68 42,20 40,95 41,00 -1,44% 2,99% 729.200
10/12/2024 40,70 42,38 40,54 41,60 +2,72% 4,52% 593.300
09/12/2024 42,03 42,58 40,30 40,50 -3,71% 5,42% 411.900
06/12/2024 41,96 42,77 41,31 42,06 +0,91% 3,47% 543.400
05/12/2024 40,74 43,05 40,70 41,68 +2,71% 5,77% 809.000
04/12/2024 41,71 42,18 40,00 40,58 -1,62% 5,23% 713.300